Anti-Proliferative and Anti-Migratory Activities of Hispidulin on Human Melanoma A2058 Cells

Chi-Jen Chang1,2, Yen-Ling Hung3, Ting-Chen Chen3

  • 1School of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.

Biomolecules
|August 6, 2021
PubMed

Insights

Hispidulin, a natural flavone, effectively combats melanoma by inducing cancer cell apoptosis and reducing metastasis. This study suggests hispidulin as a promising therapeutic candidate for melanoma treatment.

Area of Science:

  • Pharmacology
  • Oncology
  • Natural Products Chemistry

Background:

  • Melanoma is a lethal skin cancer with high metastatic potential and therapeutic resistance.
  • There is a need for effective melanoma treatments with cytotoxicity and anti-metastatic properties.
  • Hispidulin, a natural flavone, exhibits known anti-tumor and anti-inflammatory effects.

Purpose of the Study:

  • To investigate the anti-melanoma effects of hispidulin in vitro and in vivo.
  • To explore the mechanisms underlying hispidulin's anti-melanoma activity.
  • To evaluate hispidulin as a potential therapeutic agent for melanoma.

Main Methods:

  • Assessed hispidulin's effect on A2058 melanoma cell viability and apoptosis.
  • Analyzed cell cycle progression, caspase activation, and signaling pathways (AKT, ERK).
  • Evaluated reactive oxygen species generation, matrix metalloproteinase-2 (MMP-2) expression, and tumor growth in a xenograft model.

Main Results:

  • Hispidulin reduced melanoma cell viability and induced apoptosis via caspase activation (caspase 8, 9, 3) and PARP cleavage.
  • Hispidulin inhibited cell growth and survival pathways by decreasing AKT and ERK phosphorylation.
  • Hispidulin suppressed cell migration by downregulating MMP-2 and inhibited tumor growth in vivo.

Conclusions:

  • Hispidulin demonstrates potent anti-melanoma effects through apoptosis induction and migration suppression.
  • Hispidulin selectively targets melanoma cells and inhibits tumor progression.
  • Hispidulin is a promising natural therapeutic candidate for melanoma treatment.